Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding, cervical mucus and the postcoital test in levonorgestrel subcutaneous implant users

Contraception

Volumn 78, Issue 2, 2008, Pages 106-112

  Archer, David F ^a   Philput, Christine B ^b   Levine, Adam S ^c   Cullins, Vanessa ^d   Stovall, Thomas G ^e   Bacon, Janice ^f   Weber, Margaret E ^g  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b RTTP Inc   (United States)

^c Fertility and Gynecology   (United States)

^d Planned Parenthood Federation of America ^*  (United States)

^e Women's Health Specialists   (United States)

^f UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g PFIZER INC   (United States)

Author keywords

Bleeding; Double dummy; Endometrium; Ethinyl estradiol; Ibuprofen; Levonorgestrel implants; Postcoital test; Prospective; Randomized clinical trial

Indexed keywords

ETHINYLESTRADIOL; IBUPROFEN; LEVONORGESTREL; PLACEBO;

ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; FEMALE; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTCOITAL TEST; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPERM; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UTERINE CERVIX MUCUS; UTERUS BLEEDING;

ANALGESICS; CONTRACEPTIVE AGENTS, FEMALE; DOUBLE-BLIND METHOD; DRUG IMPLANTS; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HUMANS; IBUPROFEN; LEVONORGESTREL; METRORRHAGIA; PLACEBOS; TREATMENT OUTCOME;

EID: 47849104730     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.04.003     Document Type: Article

References (28)

1. Fraser I.S., and Hickey M. Endometrial vascular changes and bleeding disturbances with long-acting progestins. Steroids 65 (2000) 665-670
2. Rosenberg M.J., and Waugh M.S. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 179 3 Pt 1 (1998) 577-582
3. Sivin I. Contraception with NORPLANT implants. Hum Reprod 9 (1994) 1818-1826
4. Archer D.F., Jensen J.T., Johnson J.V., Borisute H., Grubb G.S., and Constantine G.C. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception 74 (2006) 439-445
5. Sivin I. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants. Drug Saf 26 (2003) 303-335
6. Livingstone M., and Fraser I.S. Mechanisms of abnormal uterine bleeding. Hum Reprod Update 8 (2002) 60-67
7. Gu S.J., Du M.K., Zhang L.D., Liu Y.L., Wang S.H., and Sivin I. A 5-year evaluation of NORPLANT contraceptive implants in China. Obstet Gynecol 83 5 Pt 1 (1994) 673-678
8. Diaz S., Pavez M., Miranda P., Robertson D.N., Sivin I., and Croxatto H.B. A five-year clinical trial of levonorgestrel Silastic implants (NorplantÔ). Contraception 25 (1982) 447-456
9. Shoupe D., Mishell Jr. D.R., Bopp B.L., and Fielding M. The significance of bleeding patterns in Norplant implant users. Obstet Gynecol 77 (1991) 256-260
10. Diaz J., Faundes A., Olmos P., and Diaz M. Bleeding complaints during the first year of Norplant implants use and their impact on removal rate. Contraception 53 (1996) 91-95
11. Archer D.F., Philput C.A., and Webe M.E. Management of irregular uterine bleeding and spotting associated with Norplant. Hum Reprod 11 Suppl 2 (1996) 24-30
12. Archer D.F., Mauck C.K., Viniegra-Sibal V., and Anderson F.D. Lea's Shield: a phase I postcoital study of a new contraceptive barrier device. Contraception 52 (1995) 167-173
13. Abdel-Aleem H., d'Arcangues D., Vogelsong K., and Gulmezoglu A.M. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev 2 (2007) CD003449
14. Diaz S., Croxatto H.B., Pavez M., Belhadj H., Stern J., and Sivin I. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants. Contraception 42 (1990) 97-109
15. Witjaksono J., Lau T.M., Affandi B., and Roger P.A. Oestrogen treatment for increased bleeding in Norplant users: preliminary results. Hum Reprod 11 Suppl 2 (1996) 109-114
16. Alvarez-Sanchez F., Brache V., Thevenin F., Cochon L., and Faundes A. Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol 174 (1996) 919-922
17. d'Arcangues C. Management of vaginal bleeding irregularities induced by progestin-only contraceptives. Hum Reprod 15 Suppl 3 (2000) 24-29
18. Archer D.F., Maheux R., DelConte A., and O'Brie F.B. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North American Levonorgestrel Study Group (NALSG). Am J Obstet Gynecol 181 5 Pt 2 (1999) 39-44
19. Chavez A., and DelConte A. A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study. Eur J Contracept Reprod Health Care 4 (1999) 75-83
20. Anderson F.D., and Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 68 (2003) 89-96
21. Kwiecien M., Edelman A., Nichols M.D., and Jensen J.T. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception 67 (2003) 9-13
22. Miller L., and Hughes J.P. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol 101 (2003) 653-661
23. Runic R., Schatz F., Krey L., et al. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception. J Clin Endocrinol Metab 82 (1997) 1983-1988
24. Jain J.K., Nicosi A.F., Nucatola D.L., Lu J.J., Kuo J., and Felix J.C. Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate. Steroids 68 (2003) 1115-1119
25. Weisberg E., Hickey M., Palmer D., et al. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 21 (2006) 295-302
26. d'Arcangues C., Piaggio G., Brache V., et al. Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding. Contraception 70 (2004) 451-462
27. Kaewrudee S., Taneepanichskul S., Jaisamraun U., and Reinprayoon D. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use. Contraception 60 (1999) 25-30
28. Croxatto H.B., Diaz S., Salvatierra A.M., Morales P., Ebensperger C., and Brandeis A. Treatment with Norplant subdermal implants inhibits sperm penetration through cervical mucus in vitro. Contraception 36 (1987) 193-201